RCC Panel Reacts to Long-Term Follow-Up From CheckMate 214 

A roundtable discussion, moderated by Brad McGregor, MD, focused on the latest data in RCC treatment and management, including data from the American Society of Clinical Oncology Genitourinary Cancers Symposium 2024. Dr. McGregor was joined by Rana McKay, MD; Elizabeth Wulff-Burchfield, MD; and Alan Tan, MD.
In the next segment of the roundtable series, the panel shared their thoughts on the 8-year follow-up data from CheckMate 214.